Kato M - Search Results

1

The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells.

Végran F, Berger H, Boidot R, Mignot G, Bruchard M, Dosset M, Chalmin F, Rébé C, Dérangère V, Ryffel B, Kato M, Prévost-Blondel A, Ghiringhelli F, Apetoh L. Végran F, et al. Among authors: kato m. Nat Immunol. 2014 Aug;15(8):758-66. doi: 10.1038/ni.2925. Epub 2014 Jun 29. Nat Immunol. 2014. PMID: 24973819

2

Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells.

Lengagne R, Le Gal FA, Garcette M, Fiette L, Ave P, Kato M, Briand JP, Massot C, Nakashima I, Rénia L, Guillet JG, Prévost-Blondel A. Lengagne R, et al. Among authors: kato m. Cancer Res. 2004 Feb 15;64(4):1496-501. doi: 10.1158/0008-5472.can-03-2828. Cancer Res. 2004. PMID: 14973052

3

Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases.

Lengagne R, Graff-Dubois S, Garcette M, Renia L, Kato M, Guillet JG, Engelhard VH, Avril MF, Abastado JP, Prévost-Blondel A. Lengagne R, et al. Among authors: kato m. J Immunol. 2008 Jan 1;180(1):130-7. doi: 10.4049/jimmunol.180.1.130. J Immunol. 2008. PMID: 18097012

4

Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.

El Khoury D, Destouches D, Lengagne R, Krust B, Hamma-Kourbali Y, Garcette M, Niro S, Kato M, Briand JP, Courty J, Hovanessian AG, Prévost-Blondel A. El Khoury D, et al. Among authors: kato m. BMC Cancer. 2010 Jun 24;10:325. doi: 10.1186/1471-2407-10-325. BMC Cancer. 2010. PMID: 20573279 Free PMC article.

5

T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma.

Lengagne R, Pommier A, Caron J, Douguet L, Garcette M, Kato M, Avril MF, Abastado JP, Bercovici N, Lucas B, Prévost-Blondel A. Lengagne R, et al. Among authors: kato m. PLoS One. 2011;6(5):e20235. doi: 10.1371/journal.pone.0020235. Epub 2011 May 25. PLoS One. 2011. PMID: 21633700 Free PMC article.

6

IL-18 induces PD-1-dependent immunosuppression in cancer.

Terme M, Ullrich E, Aymeric L, Meinhardt K, Desbois M, Delahaye N, Viaud S, Ryffel B, Yagita H, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Chaput N, Zitvogel L. Terme M, et al. Among authors: kato m. Cancer Res. 2011 Aug 15;71(16):5393-9. doi: 10.1158/0008-5472.CAN-11-0993. Epub 2011 Jul 1. Cancer Res. 2011. PMID: 21724589

7

Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells.

Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, Chen L, Mécheri S, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Degli-Esposti M, Chaput N, Zitvogel L. Terme M, et al. Among authors: kato m. Cancer Res. 2012 Jun 1;72(11):2757-67. doi: 10.1158/0008-5472.CAN-11-3379. Epub 2012 Mar 16. Cancer Res. 2012. PMID: 22427351

8

Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.

Pommier A, Audemard A, Durand A, Lengagne R, Delpoux A, Martin B, Douguet L, Le Campion A, Kato M, Avril MF, Auffray C, Lucas B, Prévost-Blondel A. Pommier A, et al. Among authors: kato m. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13085-90. doi: 10.1073/pnas.1300314110. Epub 2013 Jul 22. Proc Natl Acad Sci U S A. 2013. PMID: 23878221 Free PMC article.

9

Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation.

Tham M, Tan KW, Keeble J, Wang X, Hubert S, Barron L, Tan NS, Kato M, Prevost-Blondel A, Angeli V, Abastado JP. Tham M, et al. Among authors: kato m. Oncotarget. 2014 Dec 15;5(23):12027-42. doi: 10.18632/oncotarget.2482. Oncotarget. 2014. PMID: 25294815 Free PMC article.

10

Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment.

Tan KW, Evrard M, Tham M, Hong M, Huang C, Kato M, Prevost-Blondel A, Donnadieu E, Ng LG, Abastado JP. Tan KW, et al. Among authors: kato m. Oncoimmunology. 2015 Feb 25;4(2):e978709. doi: 10.4161/2162402X.2014.978709. eCollection 2015 Feb. Oncoimmunology. 2015. PMID: 25949877 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,088 results

Search Page